| Ident. | Authors (with country if any) | Title |
|---|
| 000008 (2017) |
Christopher H. Gibbons [États-Unis] ; Peter Schmidt [États-Unis] ; Italo Biaggioni [États-Unis] ; Camille Frazier-Mills [États-Unis] ; Roy Freeman [États-Unis] ; Stuart Isaacson [États-Unis] ; Beverly Karabin [États-Unis] ; Louis Kuritzky [États-Unis] ; Mark Lew [États-Unis] ; Phillip Low [États-Unis] ; Ali Mehdirad [États-Unis] ; Satish R. Raj [Canada] ; Steven Vernino [États-Unis] ; Horacio Kaufmann [États-Unis] | The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. |
| 000052 (2017) |
Elizabeth J. Slow [Canada] ; Anthony E. Lang [Canada] | Oculogyric crises: A review of phenomenology, etiology, pathogenesis, and treatment. |
| 000096 (2017) |
Olivier Girard-Joyal [Canada] ; Nafissa Ismail [Canada] | Effect of LPS treatment on tyrosine hydroxylase expression and Parkinson-like behaviors. |
| 000110 (2017) |
Melanie Tremblay [Canada] ; Mason M. Silveira [Canada] ; Sukhbir Kaur [Canada] ; Jay G. Hosking [Canada] ; Wendy K. Adams [Canada] ; Christelle Baunez [France] ; Catharine A. Winstanley [Canada] | Chronic D2/3 agonist ropinirole treatment increases preference for uncertainty in rats regardless of baseline choice patterns. |
| 000120 (2017) |
Candace H. Carriere [Canada] ; Na Hyea Kang [Canada] ; Lennard P. Niles [Canada] | Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment. |
| 000131 (2017) |
Zahra Goodarzi [Canada] ; Zahinoor Ismail [Canada] | A practical approach to detection and treatment of depression in Parkinson disease and dementia. |
| 000153 (2016) |
Qing He [République populaire de Chine] ; James B. Koprich [Canada] ; Ying Wang [République populaire de Chine] ; Wen-Bo Yu [République populaire de Chine] ; Bao-Guo Xiao [République populaire de Chine] ; Jonathan M. Brotchie [Canada] ; Jian Wang [République populaire de Chine] | Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease. |
| 000154 (2016) |
Jerry M. Cuttler [Canada] ; Eugene R. Moore [États-Unis] ; Victor D. Hosfeld [États-Unis] ; David L. Nadolski [États-Unis] | Treatment of Alzheimer Disease With CT Scans |
| 000173 (2016) |
B J Mcmahon [États-Unis] ; M G Bruce [États-Unis] ; A. Koch [Danemark] ; K J Goodman [Canada] ; V. Tsukanov [Russie] ; G. Mulvad ; M L Borresen [Danemark] ; F. Sacco [États-Unis] ; D. Barrett [États-Unis] ; S. Westby [États-Unis] ; A J Parkinson [États-Unis] | The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary. |
| 000290 (2016) |
Nathan C. Rowland [États-Unis] ; Suneil K. Kalia [Canada] ; Lorraine V. Kalia [Canada] ; Paul S. Larson [États-Unis] ; Daniel A. Lim [États-Unis] ; Krystof S. Bankiewicz [États-Unis] | Merging DBS with viral vector or stem cell implantation: “hybrid” stereotactic surgery as an evolution in the surgical treatment of Parkinson’s disease |
| 000333 (2016) |
Cicely Kerr [Royaume-Uni] ; Emily J. Lloyd [Royaume-Uni] ; Charlotte E. Kosmas [Royaume-Uni] ; Helen T. Smith [Royaume-Uni] ; James A. Cooper [Royaume-Uni] ; Karissa Johnston [Canada] ; Emma Mcintosh [Royaume-Uni] ; Andrew J. Lloyd [Royaume-Uni] | Health-related quality of life in Parkinson's: impact of 'off' time and stated treatment preferences. |
| 000337 (2016) |
Laura C. Coates [Royaume-Uni] ; Arthur Kavanaugh ; Philip J. Mease [États-Unis] ; Enrique R. Soriano [Argentine] ; Maria Laura Acosta-Felquer [Argentine] ; April W. Armstrong [États-Unis] ; Wilson Bautista-Molano [Colombie] ; Wolf-Henning Boehncke [Suisse] ; Willemina Campbell [Canada] ; Alberto Cauli [Italie] ; Luis R. Espinoza ; Oliver Fitzgerald [Irlande (pays)] ; Dafna D. Gladman [Canada] ; Alice Gottlieb [États-Unis] ; Philip S. Helliwell [Royaume-Uni] ; M Elaine Husni [États-Unis] ; Thorvardur J. Love [Islande] ; Ennio Lubrano [Italie] ; Neil Mchugh [Royaume-Uni] ; Peter Nash [Australie] ; Alexis Ogdie [États-Unis] ; Ana-Maria Orbai [États-Unis] ; Andrew Parkinson [Royaume-Uni] ; Denis O'Sullivan [Irlande (pays)] ; Cheryl F. Rosen [Canada] ; Sergio Schwartzman [États-Unis] ; Evan L. Siegel [États-Unis] ; Sergio Toloza [Argentine] ; William Tuong ; Christopher T. Ritchlin [États-Unis] | Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. |
| 000351 (2016) |
Li-Li Zhang ; S. Duff Canning [Canada] ; Xiao-Ping Wang | Freezing of Gait in Parkinsonism and its Potential Drug Treatment |
| 000372 (2016) |
Laleh Golestanirad [États-Unis] ; Behzad Elahi ; Simon J. Graham [Canada] ; Sunit Das [Canada] ; Lawrence L. Wald [États-Unis] | Efficacy and Safety of Pedunculopontine Nuclei (PPN) Deep Brain Stimulation in the Treatment of Gait Disorders: A Meta-Analysis of Clinical Studies. |
| 000395 (2016) |
Abdul Qayyum Rana ; Mohamad Saleh ; Muhammad Saad Yousuf ; Wasim Mansoor ; Syed Hussaini ; Maniza Rahman ; Zohair Iqbal | DOPA-sparing strategy in the treatment of young onset Parkinson's disease |
| 000450 (2016) |
Maribel Márquez-Cruz [Mexique] ; Juan Pablo Díaz-Martínez [Canada] ; Herman Soto-Molina [Mexique] ; Adib Jorge De Saráchaga [Mexique] ; Amin Cervantes-Arriaga [Mexique] ; Rodrigo Llorens-Arenas [Mexique] ; Mayela Rodríguez-Violante [Mexique] | A systematic review and mixed treatment comparison of monotherapy in early Parkinson's disease: implications for Latin America. |
| 000485 (2015) |
Zhen Ni ; Robert Chen | Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases |
| 000518 (2015) |
Silvia Rios Romenets [Canada] ; Julius Anang [Canada] ; Seyed-Mohammad Fereshtehnejad [Suède] ; Amelie Pelletier [Canada] ; Ronald Postuma [Canada] | Tango for treatment of motor and non-motor manifestations in Parkinson's disease: a randomized control study. |
| 000552 (2015) |
Anosha Zanjani [Canada] ; Konstantine K. Zakzanis [Canada] ; Zafiris J. Daskalakis [Canada] ; Robert Chen [Canada] | Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature. |
| 000580 (2015) |
Laurent Grégoire [Canada] ; Tara Smith [Canada] ; Vijitha Senanayake [Canada] ; Asuka Mochizuki [Japon] ; Edith Miville-Godbout [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada] | Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys. |
| 000582 (2015) |
Kaviraja Udupa [Canada] ; Susan H. Fox [Canada] | Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD. |
| 000601 (2015) |
Philip Seeman [Canada] | Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors. |
| 000742 (2015) |
Eric J. Lenze [États-Unis] ; Benoit H. Mulsant [Canada] ; Daniel M. Blumberger [Canada] ; Jordan F. Karp [États-Unis] ; John W. Newcomer [États-Unis] ; Stewart J. Anderson [États-Unis] ; Mary Amanda Dew [États-Unis] ; Meryl A. Butters [États-Unis] ; Jacqueline A. Stack [États-Unis] ; Amy E. Begley [États-Unis] ; Charles F. Reynolds [États-Unis] | Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. |
| 000748 (2015) |
Mariano Serrao [Italie] ; Alberto Ranavolo [Italie] ; Carmela Conte [Italie] ; Chiara Davassi [Italie] ; Silvia Mari [Italie] ; Alfonso Fasano [Canada] ; Giorgia Chini [Italie] ; Gianluca Coppola [Italie] ; Francesco Draicchio [Italie] ; Francesco Pierelli [Italie] | Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study. |
| 000826 (2015) |
Javier Pagonabarraga [Espagne] ; Jaime Kulisevsky [Espagne] ; Antonio P. Strafella [Canada] ; Paul Krack [France] | Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment. |
| 000871 (2014) |
Olivier Rascol [France] ; Susan Fox [Canada] ; Fabrizio Gasparini [Suisse] ; Christopher Kenney [États-Unis] ; Thérèse Di Paolo [Canada] ; Baltazar Gomez-Mancilla [Canada] | Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias. |
| 000888 (2014) |
Omid Tavassoly [Canada] ; Joe Kakish [Canada] ; Sergiy Nokhrin [Canada] ; Oleg Dmitriev [Canada] ; Jeremy S. Lee [Canada] | The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson's disease. |
| 000919 (2014) |
Renato P. Munhoz [Canada] ; Antonio Cerasa [Italie] ; Michael S. Okun [États-Unis] | Surgical Treatment of Dyskinesia in Parkinson’s Disease |
| 000930 (2014) |
A J H. Moonen [Pays-Bas] ; A. Wijers [Pays-Bas] ; A F G. Leentjens [Pays-Bas] ; C W Christine [États-Unis] ; S A Factor [États-Unis] ; J. Juncos [États-Unis] ; J M Lyness [États-Unis] ; L. Marsh [États-Unis] ; M. Panisset [Canada] ; R. Pfeiffer [États-Unis] ; D. Rottenberg [États-Unis] ; C. Serrano Ramos [Porto Rico] ; L. Shulman [États-Unis] ; C. Singer [États-Unis] ; J. Slevin [États-Unis] ; W. Mcdonald [États-Unis] ; P. Auinger [États-Unis] ; I H Richard [États-Unis] | Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. |
| 000932 (2014) |
Michel Panisset [Canada] ; Jack J. Chen ; Sean H. Rhyee ; Jill Conner ; Julie Mathena | Serotonin toxicity association with concomitant antidepressants and rasagiline treatment: retrospective study (STACCATO). |
| 000971 (2014) |
Susan H. Fox [Canada] | Pimavanserin as treatment for Parkinson's disease psychosis. |
| 000A21 (2014) |
Josée Savard [Canada] ; Hans Ivers [Canada] ; Marie-Hélène Savard [Canada] ; Charles M. Morin [Canada] | Is a Video-Based Cognitive Behavioral Therapy for Insomnia as Efficacious as a Professionally Administered Treatment in Breast Cancer? Results of a Randomized Controlled Trial |
| 000A30 (2014) |
Anthony E. Lang [Canada] ; Connie Marras [Canada] | Initiating dopaminergic treatment in Parkinson's disease. |
| 000A32 (2014) |
Alexandru Hanganu [Canada] ; Clotilde Degroot [Canada] ; Oury Monchi [Canada] ; Christophe Bedetti [Canada] ; Béatriz Mejia-Constain [Canada] ; Anne-Louise Lafontaine [Canada] ; Sylvain Chouinard [Canada] ; Marie-Andrée Bruneau [Canada] | Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease |
| 000A48 (2014) |
Vincent A. Jourdain [Canada] ; Gast N Schechtmann | Health economics and surgical treatment for Parkinson's disease in a world perspective: results from an international survey. |
| 000A68 (2014) |
Kerri A. Schoedel [Canada] ; Sarah A. Morrow [Royaume-Uni] ; Edward M. Sellers [Canada] | Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect |
| 000A80 (2014) |
Maher A. Quraan [Canada] ; Andrea B. Protzner [Canada] ; Zafiris J. Daskalakis [Canada] ; Peter Giacobbe [Canada] ; Chris W. Tang [Canada] ; Sidney H. Kennedy [Canada] ; Andres M. Lozano [Canada] ; Mary P. Mcandrews [Canada] | EEG Power Asymmetry and Functional Connectivity as a Marker of Treatment Effectiveness in DBS Surgery for Depression |
| 000B44 (2014) |
Judes Poirier [Canada] ; Justin Miron [Canada] ; Cynthia Picard [Canada] ; Patrick Gormley [Canada] ; Louise Théroux [Canada] ; John Breitner [Canada] ; Doris Dea [Canada] | Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer’s disease |
| 000B85 (2014) |
Michel Panisset [Canada] ; Jack J. Chen [États-Unis] ; Sean H. Rhyee [États-Unis] ; Jill Conner [États-Unis] ; Julie Mathena [États-Unis] | Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO) |
| 000B86 (2014) |
Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] | Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients |
| 000B87 (2014) |
Barbara S. Connolly [Canada] ; Anthony E. Lang [Canada] | Pharmacological Treatment of Parkinson Disease A Review |
| 000C31 (2013) |
Barbara Connolly [Canada] ; Susan H. Fox [Canada] | Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson’s Disease |
| 000C91 (2013) |
Abdul Qayyum Rana [Canada] ; Ishraq Siddiqui ; Masood Zangeneh ; Abdul Fattah ; Naeem Awan ; Muhammad Saad Yousuf | Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients. |
| 000C96 (2013) |
Nathan Herrmann [Canada] ; Krista L. Lanctôt [Canada] ; David B. Hogan [Canada] | Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012 |
| 000D71 (2013) |
Pedro Rosa-Neto [Canada] ; Ging-Yuek Robin Hsiung [Canada] ; Mario Masellis [Canada] | Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians |
| 000D74 (2013) |
M. T. E. Puts ; H. A. Tu ; A. Tourangeau ; D. Howell ; M. Fitch ; E. Springall ; S. M. H. Alibhai [Canada] | Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review |
| 000D84 (2013) |
Christopher Gibbons ; William Cheshire ; Alexandru Barboi ; Benjamin Levine ; Brian Olshansky ; Laurence Kinsella ; Victoria E. Claydon ; Craig Crandall ; Gregory Fink ; Michael Joyner ; Vaughan Macefield ; Lucy Norcliffe-Kaufmann ; Roy Freeman ; Satish Raj ; Julian Stewart ; Paola Sandroni ; Horacio Kaufmann ; Thomas Chelimsky | Endovascular procedures for the treatment of autonomic dysfunction |
| 000D95 (2013) |
Rajamannar Ramasubbu ; Susan Anderson ; Angela Haffenden ; Swati Chavda ; Zelma H. T. Kiss | Double-blind optimization of subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study |
| 000E08 (2013) |
Tiago A. Mestre ; Antonio P. Strafella ; Teri Thomsen ; Valerie Voon ; Janis Miyasaki | Diagnosis and treatment of impulse control disorders in patients with movement disorders |
| 000E27 (2013) |
Jean-Paul Soucy [Canada] ; Robert Bartha [Canada] ; Christian Bocti [Canada] ; Michael Borrie [Canada] ; Amer M. Burhan [Canada] ; Robert Laforce [Canada] ; Pedro Rosa-Neto [Canada] | Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012 |
| 000E29 (2013) |
Nicolas Morin [Canada] ; Marc Morissette ; Laurent Grégoire ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di Paolo | Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys. |
